The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000261.2:c.1298G>A

CA343723939

2500839 (ClinVar)

Gene: MYOC (HGNC:4653)
Condition: open-angle glaucoma (MONDO:0005338)
Inheritance Mode: Autosomal dominant inheritance
UUID: d06633f1-669c-4aa8-a43d-4f145c930b4e
Approved on: 2026-02-19
Published on: 2026-02-18

HGVS expressions

NM_000261.2:c.1298G>A
NC_000001.11:g.171636142C>T
CM000663.2:g.171636142C>T
NC_000001.10:g.171605282C>T
CM000663.1:g.171605282C>T
NC_000001.9:g.169871905C>T
NG_008859.1:g.21492G>A
ENST00000037502.11:c.1298G>A
ENST00000637303.1:c.235-2488C>T
ENST00000638471.1:c.*636G>A
ENST00000037502.10:c.1298G>A
ENST00000614688.1:c.*262G>A
NM_000261.1:c.1298G>A
More

Likely Pathogenic

Met criteria codes 3
PM2_Supporting PP3_Strong PM5
Not Met criteria codes 11
BS3 BS1 BP4 BP7 PS2 PS3 PS1 PS4 PP1 BA1 PM4

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Glaucoma Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MYOC Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Glaucoma VCEP
The c.1298G>A variant in MYOC is a missense variant predicted to cause substitution of Cysteine by Tyrosine at amino acid 433 (p.Cys433Tyr). This variant was not found in any genetic ancestry group of gnomAD (v4.1.0), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a genetic ancestry group of at least 10,000 alleles. The REVEL score = 0.956, which met the ≥ 0.932 threshold for PP3_Strong, predicting a damaging effect on MYOC function. The assays in this study (PMID: 40081751), measuring solubility and secretion of the Cys433Tyr protein, did not meet the OddsPath threshold for PS3_Supporting (> 2.1). Only 1 proband with juvenile open angle glaucoma (JOAG) had been reported (PMID: 33793440), not meeting the ≥ 2 probands threshold required to meet PS4_Supporting. Another missense variant (c.1297T>C, p.Cys433Arg, Grantham score = 180, ClinVar ID: 7956) in the same codon, has been classified as pathogenic for JOAG by the ClinGen Glaucoma VCEP. The c.1298G>A, p.Cys433Tyr variant has a higher Grantham score (= 194) than the previously classified amino acid change, was not predicted to affect splicing as assessed with SpliceAI (≤ 0.2), and met PP3, meeting the conditions for PM5 to apply. In summary, this variant met the criteria to receive a score of 6 and to be classified as likely pathogenic (likely pathogenic classification range 6 to 9, adapted from PMID: 32720330) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v2.0.0, 5 Dec 2024): PP3_Strong, PM5, PM2_Supporting (PP3 and PM5 capped at 5 points)
Met criteria codes
PM2_Supporting
This variant was not found in any genetic ancestry group of gnomAD (v4.1.0), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a genetic ancestry group of at least 10,000 alleles.
PP3_Strong
The REVEL score = 0.956, which met the ≥ 0.932 threshold for PP3_Strong, predicting a damaging effect on MYOC function.
PM5
Another missense variant (c.1297T>C, p.Cys433Arg, Grantham score = 180, ClinVar ID: 7956) in the same codon, has been classified as pathogenic for JOAG by the ClinGen Glaucoma VCEP. The c.1298G>A, p.Cys433Tyr variant has a higher Grantham score (= 194) than the previously classified amino acid change, was not predicted to affect splicing as assessed with SpliceAI (≤ 0.2), and met PP3, meeting the conditions for PM5 to apply.
Not Met criteria codes
BS3
Although the OddsPath threshold for PS3_Supporting was not met, this variant may impact protein function (see PS3 comment).

BS1
This criterion was not met as PM2_Supporting has been met.
BP4
This criterion was not met as PP3 has been met.
BP7
This is not an intronic, synonymous or non-coding variant.
PS2
This variant has not been identified de novo.
PS3
The assays in this study (PMID: 40081751), measuring solubility and secretion of the Cys433Tyr protein, did not meet the OddsPath threshold for PS3_Supporting (> 2.1).

PS1
An established LP or P variant causing this same amino acid change has not been identified.
PS4
Only 1 proband with juvenile open angle glaucoma (JOAG) had been reported (PMID: 33793440), not meeting the ≥ 2 probands threshold required to meet PS4_Supporting.
PP1
No segregations have been reported for this variant.
BA1
This criterion was not met as PM2_Supporting has been met.
PM4
This variant does not cause a protein length change.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.